Meet the Authors

Vince Piccioni

Vice President, Business Development

Roadmap to De-risk Commercialization of a Rare Disease Product

Foundations and innovation in commercial planning for a rare disease launch

With increased competition, price pressures, and customer expectations, preparing for a rare disease drug launch is more challenging than ever before. In this presentation Herspiegel with sharing our experience with rare disease product launches, including:
  • Identify critical commercial planning activities to accelerate forecast attainment
  • Assess key technology tools that can create greater visibility and responsiveness to market dynamics
  • Hear real-world examples of common roadblocks and mitigation strategies to avoid delaying your launch

Meet the Authors

Let's Talk

Herspiegel is a leading professional services firm helping biotech start-ups and the world’s largest pharmaceutical companies navigate the path from science to brand performance and change patients’ lives. We are committed to using strategic insights from medical to commercial to market access to solve critical problems.